Method for transdermal administration of gp iib/iiia antagonist

Details Method for transdermal administration of gp iib/iiia antagonist Method for transdermal administration of gp iib/iiia antagonist

A - Human Necessities

61

K

A61K 31/495 (2006.01) A61K 31/44 (2006.01) A61K 38/04 (2006.01) A61N 1/00 (2006.01) A61N 1/30 (2006.01)

Patent

CA 2269050

A method for transdermal administration of a GP IIb/IIIa antagonist by iontophoresis, comprising plural electric current application steps, progressively reduced in current density. The method insures excellent pharmacologic efficacy with a low risk for side effects in the prevention and therapy of (1) angina pectoris, (2) unstable angina and(3) ischemic complications and coronary arterial reocclusion or restenosis associated with PTCA or coronary thrombolysis.

Affiliated with

Also associated with

Rating

Method for transdermal administration of gp iib/iiia antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for transdermal administration of gp iib/iiia antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for transdermal administration of gp iib/iiia antagonist will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1718195